tiprankstipranks
Aptose Biosciences (APTO)
NASDAQ:APTO
US Market

Aptose Biosciences (APTO) Income Statement

Compare
1,285 Followers

Aptose Biosciences Income Statement

Last quarter (Q3 2024), Aptose Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Aptose Biosciences's net income was $-6.95M. See Aptose Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 52.36M$ 42.60M$ 65.45M$ 55.77M$ 26.86M
Depreciation and Amortization
$ 88.00K$ 528.00K$ 622.00K$ 614.00K$ 613.00K
EBITDA
$ -52.27M$ -42.06M$ -64.82M$ -55.16M$ -26.25M
Operating Income
$ -52.36M$ -42.59M$ -65.45M$ -55.78M$ -26.86M
Other Income/Expenses
$ 1.15M$ 779.00K$ 93.00K$ 530.00K$ 580.00K
Pretax Income
$ -51.21M$ -41.82M$ -65.35M$ -55.24M$ -26.28M
Net Income
$ -51.21M$ -41.05M$ -65.26M$ -54.71M$ -25.70M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -7.58$ -0.44$ -10.99$ -10.03$ -7.68
Diluted EPS
$ -7.58$ -0.44$ -10.99$ -10.03$ -7.68
Weighted Average Shares Outstanding
6.75M 92.27M 5.94M 5.46M 3.34M
Weighted Average Shares Outstanding (Diluted)
6.75M 92.27M 5.94M 5.46M 3.34M
Currency in USD

Aptose Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis